December 12th 2024
Today's Infection Intel discusses updates from Johnson & Johnson MedTech, Merck and Ridgeback, MicroLumix, and Evinature. Read on to learn the latest.
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses
May 2nd 2024Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?